Director Springer Reports a $4.2 Million RNAC Purchase

Steve Strazza
October 7, 2024

The most notable insider activity on today's list comes via a Form 4 filing by Cartesian Therapeutics Inc $RNAC director Timothy A. Springer.

Springer reported a $4.2 million purchase of RNAC shares.

Neuberger Berman Group LLC filed a 13G for CNX Resources Corporation $CNX, revealing an initial stake of 5.03%.

Here’s The Hot Corner, with data from October 4, 2024:

241007_hot_corner_table
Article Sales Message

Know the trading behavior of …

  • Senators
  • House Of Representatives
  • C-Suite Executives
  • Hedge Fund Managers
  • Other Big-Power Players

Our experienced team of analysts work through the Form 4, 13D and 13G filings to provide you a list of the best trade ideas.

You need to have a subscription to access this content in full.

Log in or subscribe
Filed Under: